Thermo Fisher Scientific IncNYSE:TMO
- LAST PRICE502.5000
- TODAY'S CHANGE (%)-10.5800 (-2.0621%)
- Bid / Lots502.3300/ 7
- Ask / Lots502.6700/ 8
- Open / Previous Close511.0000 / 513.0800
- Day Range
- 52 Week Range
- Volume678,217
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TMO |
|---|---|---|
| 09:32 ET | 28609 | 510.17 |
| 09:33 ET | 8039 | 510.995 |
| 09:35 ET | 7386 | 511.63 |
| 09:37 ET | 6628 | 512.73 |
| 09:39 ET | 7828 | 511.36 |
| 09:42 ET | 5676 | 510.015 |
| 09:44 ET | 3112 | 510.945 |
| 09:46 ET | 642 | 510.38 |
| 09:48 ET | 3413 | 509.265 |
| 09:50 ET | 1784 | 509.88 |
| 09:51 ET | 4699 | 509.04 |
| 09:53 ET | 3117 | 509.055 |
| 09:55 ET | 2899 | 509.72 |
| 09:57 ET | 1200 | 510.23 |
| 10:00 ET | 10613 | 509.4 |
| 10:02 ET | 9245 | 508.39 |
| 10:04 ET | 4779 | 510.085 |
| 10:06 ET | 5355 | 510.105 |
| 10:08 ET | 7752 | 510 |
| 10:09 ET | 900 | 509.97 |
| 10:11 ET | 1148 | 509.73 |
| 10:13 ET | 10772 | 508.7 |
| 10:15 ET | 3709 | 508.43 |
| 10:18 ET | 5268 | 509.125 |
| 10:20 ET | 4803 | 508.825 |
| 10:22 ET | 3356 | 508.6616 |
| 10:24 ET | 1638 | 508.46 |
| 10:26 ET | 2317 | 507.86 |
| 10:27 ET | 3071 | 506.75 |
| 10:29 ET | 3625 | 506.645 |
| 10:31 ET | 7790 | 506.4455 |
| 10:33 ET | 2562 | 507.225 |
| 10:36 ET | 1437 | 506.99 |
| 10:38 ET | 1906 | 507.26 |
| 10:40 ET | 3240 | 506.88 |
| 10:42 ET | 4395 | 506.9 |
| 10:44 ET | 6832 | 506.57 |
| 10:45 ET | 1615 | 506.74 |
| 10:47 ET | 4004 | 506.31 |
| 10:49 ET | 255 | 506.49 |
| 10:51 ET | 2707 | 506.26 |
| 10:54 ET | 1035 | 506 |
| 10:56 ET | 4051 | 506.28 |
| 10:58 ET | 4892 | 506.23 |
| 11:00 ET | 4788 | 507.13 |
| 11:02 ET | 1637 | 507.27 |
| 11:03 ET | 1173 | 507.7099 |
| 11:05 ET | 1907 | 506.605 |
| 11:07 ET | 4133 | 505.99 |
| 11:09 ET | 1372 | 505.77 |
| 11:12 ET | 834 | 505.8942 |
| 11:14 ET | 7445 | 505.32 |
| 11:16 ET | 7561 | 505.01 |
| 11:18 ET | 2082 | 504.855 |
| 11:20 ET | 2510 | 504.405 |
| 11:21 ET | 38039 | 504.6401 |
| 11:23 ET | 8536 | 505.335 |
| 11:25 ET | 8191 | 505.3 |
| 11:27 ET | 6997 | 504.86 |
| 11:30 ET | 6821 | 504.835 |
| 11:32 ET | 8990 | 505.44 |
| 11:34 ET | 5622 | 505.88 |
| 11:36 ET | 872 | 506.0799 |
| 11:38 ET | 7361 | 504.58 |
| 11:39 ET | 2393 | 504.62 |
| 11:41 ET | 3720 | 504.6899 |
| 11:43 ET | 3737 | 504.0783 |
| 11:45 ET | 2117 | 503.83 |
| 11:48 ET | 4550 | 503.26 |
| 11:50 ET | 7320 | 503.01 |
| 11:52 ET | 3445 | 502.5 |
Nov 15, 2024
DJ Thermo Fisher Board Approves New $4 Billion Stock Buyback, from 8:12AM ET on Friday Nov 15, 2024 by Dow Jones
8:12AM ET on Friday Nov 15, 2024 by Dow JonesThermo Fisher Scientific Authorizes $4 Billion of Share Repurchases, from 8:00AM ET on Friday Nov 15, 2024 by Dow Jones
8:00AM ET on Friday Nov 15, 2024 by Dow Jones*DJ Thermo Fisher Scientific Authorizes $4 Billion Of Share Repurchases >TMO, from 8:00AM ET on Friday Nov 15, 2024 by Dow Jones
8:00AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 12, 2024
Nov 11, 2024
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024, from 8:00AM ET on Monday Nov 11, 2024 by Dow Jones
8:00AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Thermo Fisher Scientific Inc | 196.3B | 31.5x | +15.48% |
Danaher Corp | 166.5B | 43.3x | +10.83% |
Intuitive Surgical Inc | 187.9B | 85.8x | +9.70% |
Boston Scientific Corp | 128.2B | 75.0x | -1.29% |
GE Healthcare Technologies Inc | 37.4B | 22.7x | --- |
Koninklijke Philips NV | 24.3B | -47.3x | --- |
Company Information
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
Contact Information
- Headquarters
- 168 Third AvenueWALTHAM, MA, United States 02451
- Phone
- 781-622-1000
- Fax
- 781-622-1207
Executives
- Chairman of the Board, President, Chief Executive Officer
- Marc Casper
- Chief Financial Officer, Senior Vice President
- Stephen Williamson
- Chief Operating Officer, Executive Vice President
- Michel Lagarde
- Chief Human Resource Officer, Senior Vice President
- Lisa Britt
- Executive Vice President
- Gianluca Pettiti
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $196.3B |
|---|---|
Revenue (TTM) | $42.4B |
Shares Outstanding | 382.5M |
Dividend Yield | 0.31% |
Annual Dividend Rate | 1.5600 USD |
Ex-Dividend Date | 12-13-24 |
Pay Date | 01-15-25 |
Beta | 0.78 |
EPS | $15.95 |
Book Value | $120.87 |
P/E Ratio | 31.5x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 20.9x |
Operating Margin | 16.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
